The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenografts
Open accessAbstract
Computer-aided lead optimization derives a unique, orally bioavailable inhibitor of the signal transducer and activator of transcription (Stat)3 Src homology 2 domain. BP-1-102 binds Stat3 with an affinity (KD) of 504 nM, blocks Stat3–phospho-tyrosine (pTyr) peptide interactions and Stat3 activation at 4–6.8 μM, and selectively inhibits growth, survival, migration, and invasion of Stat3-dependent tumor cells. BP-1-102–mediated inhibition of aberrantly active Stat3 in tumor cells suppresses the expression of c-Myc, Cyclin D1, Bcl-xL, Survivin, VEGF, and Krüppel-like factor 8, which is identified as a Stat3 target gene that promotes Stat3-mediated breast tumor cell migration and invasion. Treatment of breast cancer cells with BP-1-102 further blocks Stat3–NF-κB cross-talk, the release of granulocyte colony-stimulating factor, soluble intercellular adhesion molecule 1, macrophage migration-inhibitory factor/glycosylation-inhibiting factor, interleukin 1 receptor antagonist, and serine protease inhibitor protein 1, and the phosphorylation of focal adhesion kinase and paxillin, while enhancing E-cadherin expression. Intravenous or oral gavage delivery of BP-1-102 furnishes micromolar or microgram levels in tumor tissues and inhibits growth of human breast and lung tumor xenografts.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Jaganathan, S., Yue, P., Paladino, D. C., Bogdanovic, J., Huo, Q., & Turkson, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019605 · Cited by 162
Self-citationRetractedSTATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383 · cited 4×
“as NF-kB in the tumor microenvironment (6, 7) that redirect inflammation signal for oncogenic functions.”
BackgroundInfluentialBromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., & Darnell, J. E. (1999) · Cell · doi:10.1016/s0092-8674(00)81959-5 · Cited by 2,790
The role of STATs in transcriptional control and their impact on cellular function
Bromberg, J., & Darnell, J. E. (2000) · Oncogene · doi:10.1038/sj.onc.1203476 · Cited by 1,201 · cited 1×
“The mechanisms of Stat3-mediated tumorigenesis include dysregulation of gene expression that leads to uncontrolled growth and survival of tumor cells, enhanced tumor angiogenesis, and metastasis (3, 4).”
BackgroundTranscription factors as targets for cancer therapy
Darnell, J. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc906 · Cited by 1,194 · cited 3×
“Signal teins mediate transducer responses and activator to cytokines of transcription and growth (STAT) factors pro- (1).”
BackgroundInfluentialDangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer
Grivennikov, S. I., & Karin, M. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.11.005 · Cited by 1,160
Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells
Wang, T., Niu, G., Kortylewski, M., Burdelya, L., Shain, K., Zhang, S., Bhattacharya, R., Gabrilovich, D., Heller, R., Coppola, D., et al. (2004) · Nature Medicine · doi:10.1038/nm976 · Cited by 1,155
Siddiquee, K., Zhang, S., Guida, W. C., Blaskovich, M. A., Greedy, B., Lawrence, H. R., Yip, M. L. R., Jove, R., McLaughlin, M. M., Lawrence, N. J., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609757104 · Cited by 736
Self-citationPersistently Activated Stat3 Maintains Constitutive NF-κB Activity in Tumors
Lee, H., Herrmann, A., Deng, J.-H., Kujawski, M., Niu, G., Li, Z., Forman, S., Jove, R., Pardoll, D. M., & Yu, H. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.02.015 · Cited by 683
Stat3 Activation by Src Induces Specific Gene Regulation and Is Required for Cell Transformation
Turkson, J., Bowman, T., Garcia, R., Caldenhoven, E., De Groot, R. P., & Jove, R. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.5.2545 · Cited by 651
Self-citationThe SIF binding element confers sis/PDGF inducibility onto the c‐fos promoter.
Wagner, B. J., Hayes, T. E., Hoban, C. J., & Cochran, B. H. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07898.x · Cited by 592 · cited 2×
“(10) 4-(N-(4-Cyclohexylbenzyl)-2-(2,3,4,5,6-pentafluoro-N-methylphenylsulfonamido)acetamido)-2-hydroxybenzoic acid.”
MethodSong, H., Wang, R., Wang, S., & Lin, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409894102 · Cited by 504
Turkson, J., Ryan, D., Kim, J. S., Zhang, Y., Chen, Z., Haura, E., Laudano, A., Sebti, S., Hamilton, A. D., & Jove, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107527200 · Cited by 448
Self-citationSeidel, H. M., Milocco, L. H., Lamb, P., Darnell, J. E., Stein, R. B., & Rosen, J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.3041 · Cited by 415
Targeting STAT3 in cancer: how successful are we?
Yue, P., & Turkson, J. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780802565791 · Cited by 413
Self-citationSTAT proteins as novel targets for cancer drug discovery
Turkson, J. (2004) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.8.5.409 · Cited by 295
Self-citationTurkson, J., Bowman, T., Adnane, J., Zhang, Y., Djeu, J. Y., Sekharam, M., Frank, D. A., Holzman, L. B., Wu, J., Sebti, S., et al. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.11.7519 · Cited by 258
Self-citationTurkson, J., Kim, J. S., Zhang, S., Yuan, J., Huang, M., Glenn, M., Haura, E., Sebti, S., Hamilton, A. D., & Jove, R. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.261.3.3 · Cited by 255
Self-citationActivated Signal Transducer and Activator of Transcription (STAT) 3
Silver, D. L., Naora, H., Liu, J., Cheng, W., & Montell, D. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3959 · Cited by 252
Lin, L., Hutzen, B., Zuo, M., Ball, S., Deangelis, S., Foust, E., Pandit, B., Ihnat, M. A., Shenoy, S. S., Kulp, S., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2468 · Cited by 234
Krüppel-Like Factor 8 Induces Epithelial to Mesenchymal Transition and Epithelial Cell Invasion
Wang, X., Zheng, M., Liu, G., Xia, W., McKeown-Longo, P. J., Hung, M.-C., & Zhao, J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4729 · Cited by 191
Self-citationTurkson, J., Zhang, S., Palmer, J., Kay, H., Stanko, J., Mora, L. B., Sebti, S., Yu, H., & Jove, R. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1533.3.12 · Cited by 188
Self-citationSiddiquee, K. A. Z., Gunning, P. T., Glenn, M., Katt, W. P., Zhang, S., Schroeck, C., Sebti, S. M., Jove, R., Hamilton, A. D., & Turkson, J. (2007) · ACS Chemical Biology · doi:10.1021/cb7001973 · Cited by 187
Self-citationZhang, X., Yue, P., Fletcher, S., Zhao, W., Gunning, P. T., & Turkson, J. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.01.001 · Cited by 179
Self-citationKLF8 promotes human breast cancer cell invasion and metastasis by transcriptional activation of MMP9
Wang, X., Lu, H., Urvalek, A. M., Li, T., Yu, L., Lamar, J., DiPersio, C. M., Feustel, P. J., & Zhao, J. (2011) · Oncogene · doi:10.1038/onc.2010.563 · Cited by 163
Self-citationHigh-Throughput NMR-Based Screening with Competition Binding Experiments
Dalvit, C., Flocco, M. M., Knapp, S., Mostardini, M., Perego, R., Stockman, B. J., Veronesi, M., & Varasi, M. (2002) · Journal of the American Chemical Society · doi:10.1021/ja020174b · Cited by 155
Mandal, P. K., Gao, F., Lü, Z., Ren, Z., Ramesh, R., Birtwistle, J. S., Kaluarachchi, K., Chen, X., Bast, R. C., Liao, W. S. ‐., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2000882 · Cited by 136
Regulation of the CTL Response by Macrophage Migration Inhibitory Factor
Abe, R., Peng, T., Sailors, J., Bucala, R., & Metz, C. N. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.2.747 · Cited by 116
A Novel Sequence in the Coiled-coil Domain of Stat3 Essential for Its Nuclear Translocation
Ma, J., Zhang, T., Novotny-Diermayr, V., Tan, A. L. C., & Cao, X. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304196200 · Cited by 110
Structure-Based Design of Conformationally Constrained, Cell-Permeable STAT3 Inhibitors
Chen, J., Bai, L., Bernard, D., Nikolovska‐Coleska, Z., Gomez, C., Zhang, J., Han, Y., & Wang, S. (2010) · ACS Medicinal Chemistry Letters · doi:10.1021/ml100010j · Cited by 105
Fletcher, S., Turkson, J., & Gunning, P. T. (2008) · ChemMedChem · doi:10.1002/cmdc.200800123 · Cited by 105
Self-citationStimulation of tumor growth by human soluble intercellular adhesion molecule-1.
Gho, Y. S., Kim, P. N., Li, H. C., Elkin, M., & Kleinman, H. K. (2001) · PubMed · Cited by 103
Long term non-invasive imaging of embryonic stem cells using reporter genes
Sun, N., Lee, A. S., & Wu, J. C. (2009) · Nature Protocols · doi:10.1038/nprot.2009.100 · Cited by 100
Gouilleux, F., Moritz, D. R., Humar, M., Moriggl, R., Berchtold, S., & Groner, B. (1995) · Endocrinology · doi:10.1210/endo.136.12.7588326 · Cited by 79
Zhao, W. M., Jaganathan, S., & Turkson, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.154088 · Cited by 78
Self-citationWang, X., Urvalek, A. M., Liu, J., & Zhao, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709300200 · Cited by 70
Self-citationNielsen, H. L., Rønnov‐Jessen, L., Villadsen, R., & Petersen, O. W. (2002) · Genomics · doi:10.1006/geno.2002.6755 · Cited by 70
Gunning, P. T., Katt, W. P., Glenn, M. P., Siddiquee, K., Kim, J. S., Jove, R., Sebti, S. M., Turkson, J., & Hamilton, A. D. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.01.077 · Cited by 55
Self-citationAntagonism of the Stat3–Stat3 Protein Dimer with Salicylic Acid Based Small Molecules
Fletcher, S., Page, B. D. G., Zhang, X., Yue, P., Li, Z. H., Sharmeen, S., Singh, J., Zhao, W. M., Schimmer, A. D., Trudel, S., et al. (2011) · ChemMedChem · doi:10.1002/cmdc.201100194 · Cited by 54
Self-citationOelmann, E. M., Kraemer, A., Serve, H. L., Reufi, B., Oberberg, D., Patt, S., Herbst, H., Stein, H., Thiel, E., & Berdel, W. E. (1997) · International Journal of Cancer · Cited by 53
Binding Properties of Aromatic Carbon-Bound Fluorine
Razgulin, A. V., & Mecozzi, S. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0600702 · Cited by 50
Kim, D., Cho, I. H., Kim, H. S., Jung, J. E., Kim, J., Lee, K. H., Park, T., Yang, Y. M., Seong, S., Ye, S., et al. (2006) · Experimental & Molecular Medicine · doi:10.1038/emm.2006.49 · Cited by 48
Mandal, P. K., Ren, Z., Chen, X., Xiong, C., & McMurray, J. S. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901105k · Cited by 44
Do serum biomarkers really measure breast cancer?
Jesneck, J. L., Mukherjee, S., Yurkovetsky, Z. R., Clyde, M. A., Marks, J. R., Lokshin, A. E., & Lo, J. Y.-C. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-164 · Cited by 44
Zhang, T., Seow, K. T., Ong, C. T., & Cao, X. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m105525200 · Cited by 34
Interleukin-1 receptor antagonist mRNA expression and the progression of gastric carcinoma
Iizuka, N., Hazama, S., Hirose, K., Abe, T., Tokuda, N., Fukumoto, T., Tangoku, A., & Oka, M. (1999) · Cancer Letters · doi:10.1016/s0304-3835(99)00162-7 · Cited by 34
Hsieh, T. C., & Chiao, J. W. (1995) · Cancer Letters · doi:10.1016/0304-3835(95)03876-x · Cited by 25
Cited by
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
Johnson, D. E., O'Keefe, R. A., & Grandis, J. R. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2018.8 · Cited by 3,110
De Simone, V, Franzè, E., Ronchetti, G., Colantoni, A., Fantini, M. C., Di Fusco, D., Sica, G. S., Sileri, P., MacDonald, T. T., Pallone, F., et al. (2015) · Oncogene · doi:10.1038/onc.2014.286 · Cited by 595
Ouyang, S., Li, H., Lou, L., Huang, Q., Zhang, Z., Mo, J., Li, M., Lu, J., Zhu, K., Chu, Y., et al. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102317 · Cited by 507
Self-citationTherapeutic modulators of STAT signalling for human diseases
Miklossy, G., Hilliard, T. S., & Turkson, J. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4088 · Cited by 413
Self-citationEmerging cytokine networks in colorectal cancer
West, N. R., McCuaig, S., Franchini, F., & Powrie, F. (2015) · Nature Reviews Immunology · doi:10.1038/nri3896 · Cited by 396
Metadata
- Authors
- Zhang, X., Yue, P., Page, B. D. G., Li, T., Zhao, W., Namanja, A. T., Paladino, D., Zhao, J., Chen, Y., Gunning, P. T., & Turkson, J.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2012-05-23
- Volume
- 109
- Issue
- 24
- Pages
- 9623-9628
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2033768738
- Cited by
- 344
- References
- 47
- FWCI
- 15.34
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.